DR
Daniel Ratnaraju Pasumarthy
About Daniel Ratnaraju Pasumarthy
Data last updated:
Daniel Ratnaraju Pasumarthy has 11 years in corporate governance. Holds Managing Director role. Currently with 1 company, including Ea Labs India Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Ea Labs India Private Limited at ₹6.84 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ea Labs India Private Limited U72200AP2015PTC097286 | Managing Director | 03 Sep 2015 | 2015 | ₹6.84 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Daniel Ratnaraju Pasumarthy
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Daniel Ratnaraju Pasumarthy
Daniel Ratnaraju Pasumarthy has 11 years in corporate governance. Holds Managing Director role. Currently with 1 company, including Ea Labs India Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Ea Labs India Private Limited at ₹6.84 Cr (FY 2025).
Daniel Ratnaraju Pasumarthy is associated with 1 company as Managing Director, including Ea Labs India Private Limited (₹6.84 Cr).
Daniel Ratnaraju Pasumarthy has expertise in General Business.
Daniel Ratnaraju Pasumarthy has 11 years in corporate governance.
By reported revenue, the largest current company of Daniel Ratnaraju Pasumarthy is Ea Labs India Private Limited, with revenue of ₹6.84 Cr (FY 2025).
Daniel Ratnaraju Pasumarthy currently holds positions at 1 company: Ea Labs India Private Limited (₹6.84 Cr).